Recognize Thalassemia symptoms, distinguish between Alpha and Beta types, and understand the key indications for stem cell transplantation at Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
Thalassemia Conditions and Indications
Understanding Thalassemia requires more than just knowing the name of the disease; it requires navigating a complex spectrum of genetic conditions. For some, Thalassemia is a silent trait discovered accidentally during a routine blood test. For others, particularly those with Thalassemia Major, it is a profound clinical condition that presents in infancy with severe anemia and requires immediate, lifelong intervention.
At Liv Hospital, we believe that accurate identification is the first step toward resolution. Whether you are a parent noticing pale skin and fatigue in your child, or an adult managing the long-term effects of Cooley’s Anemia, understanding your specific “risk profile” is essential. This page outlines the specific symptoms, genetic types, and clinical indications that signal the need for advanced evaluation and potential Stem Cell Transplantation.
While the symptoms are similar, the genetic root causes differ. Thalassemia is classified by which part of the hemoglobin protein is defective: the Alpha chain or the Beta chain. Knowing your specific type is critical because it dictates the treatment pathway and the urgency of Stem Cell Transplantation.
This type is caused by deletions in the alpha-globin genes. We have four alpha genes (two from each parent). The severity depends on how many are missing:
This type is caused by mutations in the beta-globin genes. We have two beta genes (one from each parent):
Thalassemia symptoms are directly related to the lack of oxygen in the bloodstream (hypoxia). Because the body cannot produce enough healthy hemoglobin, organs are constantly “starved” of fuel. The onset of these symptoms depends heavily on the severity of the gene mutation.
In infants with severe forms, symptoms often appear within the first 6 to 24 months of life. Parents may notice that the baby is failing to gain weight, appears unusually pale or “jaundiced” (yellowing of the skin and eyes), and is frequently fussy due to fatigue. In older children and adults with intermediate forms, symptoms might be more subtle, often masked as general tiredness or low physical stamina.
Thalassemia is an autosomal recessive disorder. This means it is not contagious and cannot be developed later in life due to diet or environment. It is strictly a matter of genetic inheritance.
For a child to be born with Thalassemia Major, both parents must be carriers of the trait. If two carriers have a child, there is a:
Populations with the highest risk include those of Mediterranean (Italian, Greek, Turkish), Middle Eastern, South Asian, and African descent. If you have a family history of anemia or are from these regions, genetic carrier screening is strongly recommended before starting a family.
Not every Thalassemia patient needs a transplant. However, for those with severe forms, Stem Cell Transplantation (HSCT) is the standard of care for achieving a cure. At Liv Hospital, we follow strict international criteria to determine “Transplant Eligibility.”
The primary indication for HSCT is Transfusion Dependence. If a patient requires regular blood transfusions (every 2-4 weeks) to survive and grow, the risks of iron overload and organ damage usually outweigh the risks of the transplant.
Key Indications for Transplant:
The “Risk Factors” for a senior or adult patient are not about catching the disease, but surviving it. Without curative intervention, the body faces a dual threat: the anemia itself and the side effects of treatment.
Iron Overload (Hemosiderosis) is the most dangerous complication. Each bag of transfused blood contains iron. Because the body has no natural way to excrete this iron, it accumulates in the heart, liver, and pancreas. Over decades, this leads to fibrosis (scarring) and organ failure.
Other Critical Complications:
Send us all your questions or requests, and our expert team will assist you.
Most babies with Thalassemia Major appear healthy at birth. Symptoms typically start between 6 and 24 months, including pale skin, fussiness, poor appetite, and failure to gain weight.
Yes. Patients with Thalassemia Intermedia may manage well in childhood but develop severe symptoms such as fatigue, bone pain, or leg ulcers in their 30s or 40s as the body’s ability to compensate declines.
Generally, no. Thalassemia Minor (Trait) usually causes only mild anemia. However, it is crucial to know your status for family planning and to avoid taking unnecessary iron supplements, which can be harmful.
If you rely on regular blood transfusions to maintain a hemoglobin level above 9-10 g/dL, you are likely a candidate. A consultation with a hematologist at Liv Hospital can determine your specific eligibility score.
Yes. The heart is the organ most vulnerable to iron overload. Regular MRI monitoring (T2*) is essential to detect iron deposits early before they cause heart failure.
Your Comparison List (you must select at least 2 packages)
